| Revenue growth | Value |
|---|---|
| 3Y CAGR | +64% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +54% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,382.50 -38.90 (1.61%) | 18,414.21 | 27.16 | 5.46 | ||
PfizerPFIZER | ₹3,856.00 -0.90 (0.02%) | 17,641.24 | 20.53 | 4.2 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,373.50 +79.50 (1.26%) | 15,737.25 | 92.78 | 18.03 | ||
Natco PharmaNATCOPHARM | ₹807.00 +10.40 (1.31%) | 15,623.80 | 13.65 | 1.49 |